About Vein of Galen Malformation (VGM) | Vein of Galen Support. What is it? Angiogram of a vein of galen malformation A Vein of Galen Malformation (VOGM) is a very rare condition affecting the blood vessels of the brain. The abnormality occurs during embryonic development and results in abnormal communications between the arteries and the veins in the blood vessels of the developing brain.
The capillaries which normally connect arteries to veins and function to slow blood flow allowing for the drop off of oxygen and nutrients to the brain are missing. There are 3 categories of Vein of Galen Malformations: Neonates that present with congestive heart failure and a loud intracranial bruit (noise made by blood turbulence).Infants presenting with abnormally enlarging head, and developmental delay.Older children presenting with a large head and possibly seizures (epileptic fits) and maybe a stroke.
An MRI of a non-embolised VOGM patient How does it affect babies and children? Like this: Like Loading... Illumina, Inc. Celgene - Wiki. Celgene Corporation is an American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major products are Thalomid (thalidomide), which is approved for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum ("ENL"), as well as in combination with dexamethasone for patients with newly diagnosed multiple myeloma, and Revlimid (lenalidomide), for which the company has received FDA and EMA approval in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy.
Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. History[edit] Celgene Corporation—A Multinational Biopharmaceutical Company.